Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지

Dehydroepiandrosterone supplement increases malate dehydrogenase activity and decreases NADPH-dependent antioxidant enzyme activity in rat hepatocellular carcinogenesis

  • Kim, Jee-Won (Department of Food and Nutrition, College of Human Ecology, Seoul National University) ;
  • Kim, Sook-Hee (Department of Food and Nutrition, College of Human Ecology, Seoul National University) ;
  • Choi, Hay-Mie (Department of Food and Nutrition, College of Human Ecology, Seoul National University)
  • Published : 2008.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Beneficial effects of dehydroepiandrosterone (DHEA) supplement on age-associated chronic diseases such as cancer, cardiovascular disease, insulin resistance and diabetes, have been reported. However, its mechanism of action in hepatocellular carcinoma in vivo has not been investigated in detail. We have previously shown that during hepatocellular carcinogenesis, DHEA treatment decreases formation of preneoplastic glutathione S-transferase placental form-positive foci in the liver and has antioxidant effects. Here we aimed to determine the mechanism of actions of DHEA, in comparison to vitamin E, in a chemically-induced hepatocellular carcinoma model in rats. Sprague-Dawley rats were administered with control diet without a carcinogen, diets with 1.5% vitamin E, 0.5% DHEA and both of the compounds with a carcinogen for 6 weeks. The doses were previously reported to have anti-cancer effects in animals without known toxicities. With DHEA treatment, cytosolic malate dehydrogenase activities were significantly increased by ${\sim}5$ fold and glucose 6-phosphate dehydrogenase activities were decreased by ${\sim}25%$ compared to carcinogen treated group. Activities of Se-glutathione peroxidase in the cytotol was decreased siguificantly with DHEA treatment, confirming its antioxidative effect. However, liver microsomal cytochrome P-450 content and NADPH-dependent cytochrome P-450 reductase activities were not altered with DHEA treatment. Vitamin E treatment decreased cytosolic Se-glutathione peroxidase activities in accordance with our previous reports. However, vitamin E did not alter glucose 6-phosphate dehydrogenase or malate dehydrogenase activities. Our results suggest that DHEA may have decreased tumor nodule formation and reduced lipid peroxidation as previously reported, possibly by increasing the production of NADPH, a reducing equivalent for NADPH-dependent antioxidant enzymes. DHEA treatment tended to reduce glucose 6-phosphate dehydrogenase activities, which may have resulted in limited supply for de novo synthesis of DNA via inhibiting the hexose monophophaste pathway. Although both DHEA and vitamin E effectively reduced preneoplastic foci in this model, they seemed to fimction in different mechanisms. In conclusion, DHEA may be used to reduce hepatocellular carcinoma growth by targeting NADPH synthesis, cell proliferation and anti-oxidant enzyme activities during tumor growth.

Keywords

References

  1. Allolio B & Arlt WHahner S DHEA (2007). Why, when, and how much-DHEA replacement in adrenal insufficiency. Ann Endocrinol (Paris) 68:268-273 https://doi.org/10.1016/j.ando.2007.06.018
  2. Cerutti PA (1985). Prooxidant states and tumor promotion. Science 227:375-381 https://doi.org/10.1126/science.2981433
  3. Champe PC & Harvey RA (1987). Hexose monophosphate pathway. In : Winters R and Schott J (Eds.), Biochemistry, p.111-113. Lippincott-Raven, Philadelphia, Pennsylvania. USA
  4. Fitzpatrick JL, Ripp SL, Smith NB, Pierce WM & Jr.Prough RA (2001). Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions. Arch Biochem Biophys 389: 278-287 https://doi.org/10.1006/abbi.2001.2341
  5. Frederiks WM, Van Noordan, CJ, Aronson DC, MArx F, Bosch KS, Jonges GN, Vogels IM & James J (1990). Quantitative changes in acid phosphatase, alkaline phosphatase and 5'-nucleotidase activity in rat liver after experimentally induced cholestasis. Liver 10:158-166 https://doi.org/10.1111/j.1600-0676.1990.tb00452.x
  6. Ito N, Tsuda H, Tatematsu M, Inoue T, Tagawa Y, Aoki T, Uwagawa S, Kagawa M, Ogiso T & Masui T (1988). Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats-an approach for a new medium-term bioassay system. Carcinogenesis 9:387-394 https://doi.org/10.1093/carcin/9.3.387
  7. Kim S & Choi H (2005). Effects of vitamin E and dehydroepiandrosterone on the formation of preneoplastic lesions in rat hepatocellular carcinogenesis. The Korean Journal of Nutrition 38:364-372
  8. Labrie F (2007). Drug insight: breast cancer prevention and tissuetargeted hormone replacement therapy. Nat Clin Pract Endocrinol Metab 3:584-593 https://doi.org/10.1038/ncpendmet0559
  9. Ladriere L, Laghmich A, Malaisse-Lagae F & Alaisse WJ (1997). Effect of dehydroepiandrosterone in hereditarily diabetic rat. Cell Biochem Funct 15:287-292 https://doi.org/10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X
  10. Lohr GW & Waller HD (1974). Glucose 6-phosphate dehydrogenase. In:Bergmeyer HU (Ed.), Methods in enzymatic analysis, (2) p.636-643. AP., New York. USA
  11. Marrero M, Prough RA, Frenkel RA & Milewich L (1990). Dehydroepiandrosterone feeding and protein phosphorylation, phosphatases, and lipogenic enzymes in mouse liver. Proc Soc Exp Biol Med 193:110-117
  12. Muller A & Pallauf J (2003). Effect of increasing selenite concentrations, vitamin E supplementation and different fetal calf serum content on GPx1 activity in primary cultured rabbit hepatocytes. J Trace Elem Med Biol 17:183-192 https://doi.org/10.1016/S0946-672X(03)80024-X
  13. Ochoa S (1969). Malic enzyme. In: Lowenstein JM (Ed.), Methods in enzymology, p.230-237. AP., New York. USA
  14. Omura T & Sato R (1964). The Carbon Monoxide-Binding Pigment of Liver Microsomes. I. Evidence for Its Hemoprotein Nature. J Biol Chem 239:2370-2378
  15. Roberge C, Carpentier C, Langlois M, Baillargeon J, Ardilouze J, Maheux P, & Gallo-Payet N (2007). Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity. Am J Physiol Endocrinol Metab 293:E1465-1478 https://doi.org/10.1152/ajpendo.00516.2007
  16. Tappel AL (1978). Glutathione peroxidase and hydroperoxides. Methods Enzymol 52:506-513 https://doi.org/10.1016/S0076-6879(78)52055-7
  17. Wu HQ, Masset-Brown J, Tweedie DJ, Milewich L, Frenkel RA, Martin-Wixtrom C, Estabrook RW & Prough RA (1989). Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator. Cancer Res 49: 2337-2343
  18. Zhao S, Ma H, Zou S & Chen W (2007). Effects of in ovo administration of DHEA on lipid metabolism and hepatic lipogenetic genes expression in broiler chickens during embryonic development. Lipids 42:749-757 https://doi.org/10.1007/s11745-007-3068-y